跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IXIA 40 mg COMPRIMIDOS RECUBIERTOS - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
IXIA 40 mg COMPRIMIDOS RECUBIERTOS
Approved
STANDARD
IXIA 40 mg COMPRIMIDOS RECUBIERTOS
Menarini International Operations Luxembourg S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Nov 13, 2020
Approval ID
4362dafc555a4f22
Company
Menarini International Operations Luxembourg S.A.
Type
Standard
Approval Details
Approval Id
4362dafc555a4f22
Drug Cima Aemps Name
IXIA 40 mg COMPRIMIDOS RECUBIERTOS
Register Number
036026110IP2
Holder Company Name
Menarini International Operations Luxembourg S.A.
Marketing Company Name
Melyfarma S.L.
Holder Company Detail Path
/organization/menarini-international-operations-luxembourg-s-a
Authorization Date
2020-11-13
Dosage Form
COMPRIMIDO RECUBIERTO
Dose
40 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Menarini International Operations Luxembourg S.A.
Company Detail Path
/organization/menarini-international-operations-luxembourg-s-a
Company Information
Pharmaceutical Company Name
MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A.
Country Name
Luxembourg
City Name
luxembourg,country_lu
Address
Avenue de la Gare 1
Active Ingredients
OLMESARTAN MEDOXOMILO
40,00 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Nov 13, 2020
Approval ID
4362dafc555a4f22
Type
Standard
Back to CIMA-AEMPS Approvals